Clinical Data

Darts failing to hit bullseye
Biotech

Aviceda eye disease hopeful fails to top Astellas med in phase 2

Aviceda was also testing the nanoparticle in diabetic macular edema, but halted the study early due to insufficient supply and funding constraints.
Darren Incorvaia Dec 15, 2025 2:14pm
hooded boxer in boxing ring

Immunome's desmoid tumor treatment triumphs in phase 3

Dec 15, 2025 10:42am
Cartoon of businessmen standing around a broken target

Arcus halts Gilead-partnered TIGIT trials as it reworks R&D

Dec 12, 2025 10:00am
stock image of a glucose meter with a blood strip

Rezolute stock sinks 87% as hypoglycemia drug fails ph. 3 test

Dec 11, 2025 9:45am
obesity overweight weight loss weigh

Lilly's obesity triple threat tops phase 3 efficacy forecasts

Dec 11, 2025 8:15am
Lung

GRI touts IPF safety edge, lung function gains amid cash crunch

Dec 11, 2025 5:12am